Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB1310 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human u-Plasminogen Activator/Urokinase Catalytic Domain Monoclonal Antibody (Clone 204212)
- Antibody type
- Monoclonal
- Antigen
- Mouse myeloma cell line NS0-derived recombinant human u-Plasminogen Activator (uPA)/Urokinase Catalytic Domain, Ser21-Leu431
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
P00749- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Loss of N-Myc interactor promotes epithelial-mesenchymal transition by activation of TGF-β/SMAD signaling.
Transcription factor AP-2α promotes EGF-dependent invasion of human trophoblast.
AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor.
Devine DJ, Rostas JW, Metge BJ, Das S, Mulekar MS, Tucker JA, Grizzle WE, Buchsbaum DJ, Shevde LA, Samant RS
Oncogene 2014 May 15;33(20):2620-8
Oncogene 2014 May 15;33(20):2620-8
Transcription factor AP-2α promotes EGF-dependent invasion of human trophoblast.
Biadasiewicz K, Sonderegger S, Haslinger P, Haider S, Saleh L, Fiala C, Pollheimer J, Knöfler M
Endocrinology 2011 Apr;152(4):1458-69
Endocrinology 2011 Apr;152(4):1458-69
AP-1-controlled hepatocyte growth factor activation promotes keratinocyte migration via CEACAM1 and urokinase plasminogen activator/urokinase plasminogen receptor.
Schnickmann S, Camacho-Trullio D, Bissinger M, Eils R, Angel P, Schirmacher P, Szabowski A, Breuhahn K
The Journal of investigative dermatology 2009 May;129(5):1140-8
The Journal of investigative dermatology 2009 May;129(5):1140-8
No comments: Submit comment
No validations: Submit validation data